{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:20:41Z","timestamp":1781850041266,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jprot.2020.103723","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T11:23:32Z","timestamp":1582975412000},"page":"103723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study"],"prefix":"10.1016","volume":"218","author":[{"given":"Julia","family":"Oto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Fern\u00e1ndez-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa. Jos\u00e9","family":"Solmoirago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar D.","family":"Vera-Donoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mart\u00ednez-Sarmiento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2020.103723_bb0005","doi-asserted-by":"crossref","first-page":"g4797","DOI":"10.1136\/bmj.g4797","article-title":"Renal cell carcinoma","volume":"349","author":"Jonasch","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jprot.2020.103723_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jprot.2020.103723_bb0015","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jprot.2020.103723_bb0020","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jprot.2020.103723_bb0025","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1464-410X.2008.07451.x","article-title":"The changing pattern of kidney cancer incidence and mortality in europe","volume":"101","author":"Levi","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.jprot.2020.103723_bb0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/CBM-2011-0176","article-title":"Renal cell carcinoma","volume":"9","author":"Cairns","year":"2010","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.jprot.2020.103723_bb0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/0100-3984.2013.1927","article-title":"Renal cell carcinoma: histological classification and correlation with imaging findings","volume":"48","author":"Muglia","year":"2015","journal-title":"Radiol. Bras."},{"key":"10.1016\/j.jprot.2020.103723_bb0040","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.eururo.2006.04.009","article-title":"Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision","volume":"50","author":"Ficarra","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jprot.2020.103723_bb0045","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.2174\/092986712801661103","article-title":"Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis","volume":"19","author":"Urquidi","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jprot.2020.103723_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jprot.2018.09.020","article-title":"Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease","volume":"193","author":"Canadas-Garre","year":"2019","journal-title":"J. Proteome"},{"key":"10.1016\/j.jprot.2020.103723_bb0055","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jprot.2011.10.027","article-title":"Recent and potential developments of biofluid analyses in metabolomics","volume":"75","author":"Zhang","year":"2012","journal-title":"J. Proteome"},{"key":"10.1016\/j.jprot.2020.103723_bb0060","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jprot.2020.103723_bb0065","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jprot.2013.07.018","article-title":"Proteomic identification of reticulocalbin 1 as potential tumor marker in renal cell carcinoma","volume":"91","author":"Giribaldi","year":"2013","journal-title":"J. Proteome"},{"key":"10.1016\/j.jprot.2020.103723_bb0070","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1158\/0008-5472.CAN-14-1703","article-title":"Grade-dependent metabolic reprogramming in kidney cancer revealed by combined proteomics and metabolomics analysis","volume":"75","author":"Wettersten","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.jprot.2020.103723_bb0075","doi-asserted-by":"crossref","first-page":"15635","DOI":"10.1038\/s41598-019-52059-y","article-title":"Lc-ms based metabolomic profiling for renal cell carcinoma histologic subtypes","volume":"9","author":"Jing","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jprot.2020.103723_bb0080","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ijc.32115","article-title":"Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma","volume":"145","author":"Sato","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jprot.2020.103723_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jprot.2018.04.028","article-title":"Histology-guided proteomic analysis to investigate the molecular profiles of clear cell renal cell carcinoma grades","volume":"191","author":"Stella","year":"2019","journal-title":"J. Proteome"},{"key":"10.1016\/j.jprot.2020.103723_bb0090","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1007\/s00216-018-1059-x","article-title":"Metabolomic study of human tissue and urine in clear cell renal carcinoma by lc-hrms and pls-da","volume":"410","author":"Niziol","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jprot.2020.103723_bb0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/metabo7010006","article-title":"Urine and serum metabolomics analyses may distinguish between stages of renal cell carcinoma","volume":"7","author":"Falegan","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.jprot.2020.103723_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jprot.2018.04.029","article-title":"Proteomics of liquid biopsies: depicting rcc infiltration into the renal vein by ms analysis of urine and plasma","volume":"191","author":"Chinello","year":"2019","journal-title":"J. Proteome"},{"key":"10.1016\/j.jprot.2020.103723_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ab.2007.01.028","article-title":"A comprehensive urinary metabolomic approach for identifying kidney cancerr","volume":"363","author":"Kind","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jprot.2020.103723_bb0110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1074\/mcp.M800165-MCP200","article-title":"Urine metabolomics analysis for kidney cancer detection and biomarker discovery","volume":"8","author":"Kim","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jprot.2020.103723_bb0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/omi.2010.0094","article-title":"Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer","volume":"15","author":"Kim","year":"2011","journal-title":"OMICS"},{"key":"10.1016\/j.jprot.2020.103723_bb0120","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/ijc.26274","article-title":"Urinary acylcarnitines are altered in human kidney cancer","volume":"130","author":"Ganti","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jprot.2020.103723_bb0125","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.ejca.2014.04.011","article-title":"Analysis of volatile human urinary metabolome by solid-phase microextraction in combination with gas chromatography-mass spectrometry for biomarker discovery: application in a pilot study to discriminate patients with renal cell carcinoma","volume":"50","author":"Monteiro","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jprot.2020.103723_bb0130","doi-asserted-by":"crossref","first-page":"37275","DOI":"10.1038\/srep37275","article-title":"Nuclear magnetic resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma","volume":"6","author":"Monteiro","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jprot.2020.103723_bb0135","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fonc.2019.00663","article-title":"Urine metabolomics for renal cell carcinoma (rcc) prediction: tryptophan metabolism as an important pathway in rcc","volume":"9","author":"Liu","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jprot.2020.103723_bb0140","article-title":"The role of the p-value in the multitesting problem","author":"Mart\u00ednez-Camblor","year":"2019","journal-title":"J. Appl. Stat."},{"key":"10.1016\/j.jprot.2020.103723_bb0145","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.urolonc.2011.05.013","article-title":"Urine metabolomics for kidney cancer detection and biomarker discovery","volume":"29","author":"Ganti","year":"2011","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.jprot.2020.103723_bb0150","first-page":"30277","article-title":"A decision analysis evaluating screening for kidney cancer using focused renal ultrasound","volume":"19","author":"Rossi","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.jprot.2020.103723_bb0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1245\/s10434-014-4031-9","article-title":"False-positive rate of positron emission tomography\/computed tomography for presumed solitary metastatic adrenal disease in patients with known malignancy","volume":"22","author":"Kuritzkes","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jprot.2020.103723_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cpet.2015.03.002","article-title":"Pet\/computed tomography in renal, bladder, and testicular cancer","volume":"10","author":"Bouchelouche","year":"2015","journal-title":"PET Clin."},{"key":"10.1016\/j.jprot.2020.103723_bb0165","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ki.2011.504","article-title":"Uremic solutes from colon microbes","volume":"81","author":"Meyer","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.jprot.2020.103723_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/0886022X.2018.1561376","article-title":"Review of the efficacy of ast-120 (kremezin((r))) on renal function in chronic kidney disease patients","volume":"41","author":"Asai","year":"2019","journal-title":"Ren. Fail."},{"key":"10.1016\/j.jprot.2020.103723_bb0175","doi-asserted-by":"crossref","first-page":"22526","DOI":"10.1038\/srep22526","article-title":"Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given ast-120","volume":"6","author":"Velenosi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jprot.2020.103723_bb0180","first-page":"29","article-title":"Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: implications for chronic kidney disease pathophysiology","volume":"2015","author":"Mutsaers","year":"1868","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.jprot.2020.103723_bb0185","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1021\/pr4000448","article-title":"Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry","volume":"12","author":"Pasikanti","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jprot.2020.103723_bb0190","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00394-007-0684-5","article-title":"Effects of orange juice and proline betaine on glycine betaine and homocysteine in healthy male subjects","volume":"46","author":"Atkinson","year":"2007","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.jprot.2020.103723_bb0195","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1038\/s41598-019-42992-3","article-title":"Untargeted metabolomics reveals n, n, n-trimethyl-l-alanyl-l-proline betaine (tmap) as a novel biomarker of kidney function","volume":"9","author":"Velenosi","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391920300919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391920300919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:04:04Z","timestamp":1761739444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391920300919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":39,"alternative-id":["S1874391920300919"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2020.103723","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2020.103723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103723"}}